大柴胡颗粒治疗慢性胆囊炎肝胆郁热证的临床研究

陈静; 沈洪; 林越汉; 廖恒祥; 江一平; 王垂杰; 金小晶; 苏娟萍; 邵凤珍; 邹建东; 刘芳

大柴胡颗粒治疗慢性胆囊炎肝胆郁热证的临床研究

1.
南京中医药大学附属医院，江苏南京 210029
2.
福建中医药大学附属人民医院，福建福州 350003
3.
湖北省中医院肝胆外科，湖北武汉 430061
4.
江西中医药大学附属医院，江西南昌 330000
5.
辽宁中医药大学附属医院，辽宁沈阳 110000
6.
南京市中医院消化科，江苏南京 210000
7.
山西省中医药研究院脾胃病科，山西太原 030000
8.
天津中医药大学第一附属医院，天津 300000

计量
- 文章访问数: 1294
- HTML全文浏览量: 9
- PDF下载量: 1350
- 被引次数: 0
出版历程
- 收稿日期: 2016-12-11
- 修回日期: 2017-04-12
- 刊出日期: 2017-07-10

Clinical Research on Dachaihu Granule in Treating Chronic Cholecystitis Due to Stagnant Heat in Liver and Gallbladder

1.
Affiliated Hospital of Nanjing University of Chinese Medicine, Nanjing, 210029, China
2.
Fujian Research Institute of Traditional Chinese Medicine, Fuzhou, 350003, China
3.
Hubei Provincial Hospital of Traditional Chinese Medicine, Wuhan, 430061, China
4.
The Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine, Nanchang, 330000, China
5.
The Affiliated Hospital of Liaoning University of Traditional Chinese Medicine, Shenyang, 110000, China
6.
Nanjing City Hospital of Traditional Chinese Medicine, Nanjing, 210000, China
7.
Shanxi Research Institute of Traditional Chinese Medicine, Taiyuan, 030000, China
8.
The First Affiliated Hospital of Tianjin University of Traditional Chinese Medicine, Tianjin, 300000, China

摘要

摘要: 目的评价大柴胡颗粒治疗慢性胆囊炎胆腑郁热证的有效性、安全性。方法采用分层区组随机、双盲、安慰剂及阳性药对照法，选取8个中心慢性胆囊炎患者600例，试验组∶安慰剂组∶利胆片组为360∶120∶120例。分别口服大柴胡颗粒及利胆片模拟剂、大柴胡颗粒模拟剂及利胆片模拟剂、大柴胡颗粒模拟剂及利胆片，7d后进行疗效及安全性评价。结果 ①中医证候综合疗效；右上腹部疼痛记分减少分布情况及消失率；患者对右上腹疼痛缓解的评价；症状总积分；口苦、口渴、大便秘结、小便黄记分减少分布情况及阳性症状消失率、呕吐症状消失率、超声莫菲氏征变化，试验组与阳性药组无差异，试验组、阳性药组均优于安慰剂组（P<0.05~0.01）。②发热、恶心治疗后记分减少分布情况及阳性症状消失率、呕吐记分减少分布情况，试验组、阳性药组与安慰剂组无显著性差异。③安全性良好。结论大柴胡颗粒治疗慢性胆囊炎胆腑郁热证安全有效。
- 慢性胆囊炎 /
- 胆腑郁热证 /
- 大柴胡颗粒 /
- 利胆片 /
- 临床研究
Abstract: OBJECTIVE To evaluate the validity and safety of Dachaihu Granule in treating chronic cholecystitis due to Stagnant Heat in Liver and Gallbladder. METHODS A stratified-block randomized， double-blind， double-dummy， parallel， placebo-controlled trial was designed， with 600 cases with chronic cholecystitis from 8 centers being selected and the ratio of treatment group， placebo group and cholagogic tablet group being 360∶120∶120. Patients in different groups were separately given Dachaihu Granule and cholagogic tablet simulator， Dachaihu Granule simulator and cholagogic tablet simulator， Dachaihu Granule simulator and cholagogic tablet. Then the validity and safety were assessed after 7 days' treatment. RESULTS ①In terms of the comprehensive curative effect of TCM syndromes， it was noticed that there existed no difference between the treatment group and positive medicine group in the integral reduction and disappearance of upper quadrant pain and tenderness， quadrant pain relief evaluated by patients， total symptom scores， integral reduction and disappearance of bitter taste， thirst， constipation and yellow urine， disappearance of vomit， change of gallbladder wall thickness and ultrasonic Murphy's character before and after the treatment， while both the treatment group and positive medicine group were superior to the placebo group(P<0.05~0.01). ②The treatment group and positive medicine group has no difference from the placebo group in integral reduction and disappearance o ffever and nausea integral reduction of vomit， change of gallbladder size and inside diameter of common bile duct. ③Good safety was noticed. CONCLUSION Chronic cholecystitis due to stagnant heat in liver and gallbladder treated by Dachaihu Granule is safe and effective.
- chronic cholecystitis /
- stagnant heat in liver and gallbladder /
- Dachaihu Granule /
- cholagogic tablet /
- clinical research

HTML全文

参考文献(12)

[1]	林洪生，刘杰，李勇，等．多中心中医临床研究的实施管理与质量控制实践[J]．世界科学技术——中医药现代化，2012， 14（1）：1277-1281．
[2]	LIN HS， LIU J， LI Y， et al. Management and quality control practices in multicenter clinical study of Chinese medicine[J]. World Sci Tech: Mod Trad Chin Med Mater Med， 2012， 14 (1): 1277-1281.
[3]	王均海.柴胡疏肝散治疗慢性胆囊炎随机平行对照研究[J].实用中医内科杂志，2014，28(7):30-32.
[4]	WANG JH. A randomized controlled study of Chaihu Shugan Powder on chronic cholecystitis[J]. Pract Tradit Chin Intern Med， 2014， 28 (7): 30-32.
[5]	高文艳，林一帆，杨国玉，等．胆石片治疗伴胆囊结石的慢性胆囊炎肝胆气郁证:随机、双盲、对照临床试验[J]．中国中西医结合消化杂志，2014， 22（12）：717-720， 724．
[6]	GAO WY， LIN YF， YANG GY， et al. Danshi tablet in the treatment of chronic cholecystitis complicated with gallbladder stones patients with hepatobiliary-qi stagnation syndrome:a randomized doublle-blind controlled trial[J]. Chin J Integr Tradit West Med Dig， 2014， 22 (12): 717-720， 724.
[7]	中药新药临床研究指导原则: 试行[M]．北京：中国医药科技出版社，2002：134．
[8]	Guiding Principle of Clinical Research on New Drugs of Traditional Chinese Medicine(Trial)[M]. Beijing: China medical science and technology press， 2002: 134.
[9]	陈佑邦，潘筱秦，金棣生，等.中医病证分类与代码[M].北京：中国标准出版社，1995：9.
[10]	CHEN YB， PAN XQ， JIN DS， et al. The Classification and Code of TCM Disease Category[M]. Beijing: China standards press， 1995: 9.
[11]	李志庸.张景岳医学全书[M].北京：中国中医药出版社，2015:170.
[12]	LI ZY. The Complete Works of Zhang Jingyue[M]. Beijing: Chinese medicine press，2015:170.